News

STAT12h
U.S. health officials inject new uncertainty into approval process for Covid boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
As FDA delays Novavax' COVID vaccine approval, patients fight back
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
BioSpace4d
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children: Politico
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...
News-Medical.Net10d
What the Newest mRNA Vaccines Could Do Beyond COVID
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from COVID-19 to personalized cancer therapies.
Novavax shares soar after FDA request raises hope for COVID vaccine approval
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
CDC advisory group considers narrowing COVID vaccine recommendations
Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...
Special Writer, The Wall Street Journal
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...